Form 4: Rockwell Medical SVP and CCO Timothy Chole Sells Shares Under Pre-Arranged Trading Plan

Timothy Chole, Senior Vice President and Chief Commercial Officer of Rockwell Medical, Inc., sold 2,868 shares of common stock for $0.82 per share as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Timothy Chole, SVP and CCO of Rockwell Medical, Inc. (RMTI), sold 2,868 shares of the company's common stock.
• The transaction occurred on July 1, 2025, at a weighted average price of $0.82 per share, with prices ranging from $0.80 to $0.83.
• Following this sale, Timothy Chole directly beneficially owns 128,167 shares of Rockwell Medical common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Chole on June 7, 2024.

Sentiment

Score: 5

Explanation: The sale of shares by an insider is generally a neutral to slightly negative signal. However, the fact that it was executed under a pre-arranged Rule 10b5-1 trading plan mitigates concerns about opportunistic selling, making the overall sentiment neutral.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can reduce concerns about opportunistic insider selling.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the direct ownership stake of a key executive, which some investors might interpret as a slight reduction in alignment of interests or confidence, though this is mitigated by the pre-planned nature.

Risks

• The sale of shares by a Senior Vice President and Chief Commercial Officer, even if pre-planned, could be perceived by some investors as a lack of strong conviction in the company's near-term stock performance, potentially leading to negative sentiment.

Future Outlook

NA

Management Comments

• This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024 in multiple trades at prices ranging from $0.80 to $0.83. The price reported above reflects the weighted average sales price.
• The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

This Form 4 filing details an individual insider transaction, which is specific to Rockwell Medical, Inc. and its executive Timothy Chole. It does not directly reflect broader industry trends or competitive dynamics, though insider activity can be a data point for investors evaluating a company within its sector.

Related Party Transactions

• The sale of common stock by Timothy Chole, a Senior Vice President and Chief Commercial Officer, constitutes a related party transaction as it involves a key executive of the company.

Stakeholder Impact

• Shareholders: The sale reduces the direct ownership stake of a key executive, which could be interpreted by some as a minor negative signal, though the 10b5-1 plan mitigates this.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the Issuer, or a security holder of the Issuer.

Key Dates

Keywords

Rockwell Medical, RMTI, Timothy Chole, Insider Trading, SEC Form 4, Stock Sale, Rule 10b5-1, Executive Compensation, Common Stock